Artificial Cells Nanomedicine And Biotechnology SCIE

国际简称：ARTIF CELL NANOMED B 参考译名：人工细胞纳米医学与生物技术

主要研究方向：ENGINEERING, BIOMEDICAL-BIOTECHNOLOGY & APPLIED MICROBIOLOGY 预警期刊审稿周期： 20 Weeks

《人工细胞纳米医学与生物技术》(Artificial Cells Nanomedicine And Biotechnology)是一本由Informa Healthcare出版的以ENGINEERING, BIOMEDICAL-BIOTECHNOLOGY & APPLIED MICROBIOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊。

3区中科院分区
Q1 JCR分区
53 年发文量
4.5 IF影响因子
未开放 是否OA
35 H-index
2013 创刊年份
1 issue/year 出版周期
English 出版语言

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

[ 查看全部 ]

投稿咨询加急咨询

Artificial Cells Nanomedicine And Biotechnology期刊信息

ISSN：2169-1401
出版语言：English
是否OA：未开放
E-ISSN：2169-141X
出版地区：UNITED STATES
是否预警：是
出版商：Informa Healthcare
出版周期：1 issue/year
创刊时间：2013
开源占比：0.9865
Gold OA文章占比：98.61%
OA被引用占比：0.4587...
出版国人文章占比：0.46
出版撤稿占比：0.1759...
研究类文章占比：90.57%

Artificial Cells Nanomedicine And Biotechnology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

10.9

0.646

0.903

学科类别	分区	排名	百分位
大类：Medicine 小类：Medicine (miscellaneous)	Q1	29 / 398	92%
大类：Medicine 小类：Pharmaceutical Science	Q1	14 / 183	92%
大类：Medicine 小类：Biomedical Engineering	Q1	36 / 303	88%
大类：Medicine 小类：Biotechnology	Q1	40 / 311	87%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Artificial Cells Nanomedicine And Biotechnology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	生物学	3区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	3区 3区 4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	工程技术	2区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	2区 2区 2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	工程技术	2区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	2区 3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	2区 2区 3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	工程技术	2区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	2区 3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	工程技术	3区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 ENGINEERING, BIOMEDICAL 工程：生物医学 MATERIALS SCIENCE, BIOMATERIALS 材料科学：生物材料	3区 4区 4区

Artificial Cells Nanomedicine And Biotechnology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.7%
学科：ENGINEERING, BIOMEDICAL	SCIE	Q2	35 / 122	71.7%
学科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	22 / 53	59.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.75%
学科：ENGINEERING, BIOMEDICAL	SCIE	Q2	31 / 122	75%
学科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	14 / 53	74.53%

Artificial Cells Nanomedicine And Biotechnology历年数据统计

影响因子

中科院分区

Artificial Cells Nanomedicine And Biotechnology中国学者发文选摘

1、The Rhei radix rhizoma-based carbon dots ameliorates dextran sodium sulphate-induced ulcerative colitis in mice
Author: Zhang, Yifan; Zhao, Jie; Zhao, Yusheng; Bai, Xue; Chen, Yumin; Liu, Yuhan; Zhang, Yue; Kong, Hui; Qu, Huihua; Zhao, Yan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 180-191. DOI: 10.1080/21691401.2023.2197947
2、a-Lipoic acid loaded hollow gold nanoparticles designed for osteoporosis treatment: preparation, characterization and in vitro evaluation
Author: Xi, Yanhai; Pan, Wenming; Liu, Yanyan; Liu, Ji; Xu, Guohua; Su, Yanguo; Chen, Daquan; Ye, Xiaojian

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 131-138. DOI: 10.1080/21691401.2022.2149542
3、Simple and feasible detection of hepatitis a virus using reverse transcription multienzyme isothermal rapid amplification and lateral flow dipsticks without standard PCR laboratory
Author: Sun, Mao-ling; Zhong, Yang; Li, Xiao-na; Yao, Jun; Pan, Yu-qing

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 233-240. DOI: 10.1080/21691401.2023.2203198
4、Identification of stemness subtypes and features to improve endometrial cancer treatment using machine learning
Author: Lu, Xiaoqin; Ying, Yanqi; Zhang, Wenyi; Li, Rui; Wang, Wuliang

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 57-73. DOI: 10.1080/21691401.2023.2172027
5、PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
Author: Li, Bingting; Zhang, Jun; Ma, Ning; Li, Weidan; You, Guoxing; Chen, Gan; Zhao, Lian; Wang, Quan; Zhou, Hong

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 120-130. DOI: 10.1080/21691401.2023.2176865
6、Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer
Author: Guo, Chunjing; Zhang, Wei; Zhang, Qiaoyun; Su, Yanguo; Hou, Xiaoya; Chen, Qiang; Guo, Huimin; Kong, Ming; Chen, Daquan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 170-179. DOI: 10.1080/21691401.2023.2193221
7、Exploration of effective biomarkers and infiltrating Immune cells in Osteoarthritis based on bioinformatics analysis
Author: Cheng, Piaotao; Gong, Shouhang; Guo, Caopei; Kong, Ping; Li, Chencheng; Yang, Chengbing; Zhang, Tao; Peng, Jiachen

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 242-254. DOI: 10.1080/21691401.2023.2185627
8、A novel PDT: 5-aminolevulinic acid combined 450 nm blue laser photodynamic therapy significantly promotes cell death of HR-HPV infected cells
Author: Chen, Yuqing; Mei, Yibo; Gu, Lijiang; Li, Xing; Guo, Peng; Chen, Lihong; He, Dalin

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 22-32. DOI: 10.1080/21691401.2022.2164585